KRAS and cancer: We found that HERVs associated with poor overall survival were generally more likely to be expressed in the presence of somatic mutations in frequently mutated cancer driver genes, such as TP53, KRAS, ARID1A, and PTEN (using hypergeometric enrichment, Supplementary Data 7).